JP2024535596A - ヒト免疫不全ウイルス複製の阻害薬 - Google Patents
ヒト免疫不全ウイルス複製の阻害薬 Download PDFInfo
- Publication number
- JP2024535596A JP2024535596A JP2024522260A JP2024522260A JP2024535596A JP 2024535596 A JP2024535596 A JP 2024535596A JP 2024522260 A JP2024522260 A JP 2024522260A JP 2024522260 A JP2024522260 A JP 2024522260A JP 2024535596 A JP2024535596 A JP 2024535596A
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- compound
- formula
- weight
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163255056P | 2021-10-13 | 2021-10-13 | |
| US63/255,056 | 2021-10-13 | ||
| US202163257212P | 2021-10-19 | 2021-10-19 | |
| US63/257,212 | 2021-10-19 | ||
| PCT/IB2022/059780 WO2023062559A1 (en) | 2021-10-13 | 2022-10-12 | Inhibitors of human immunodeficiency virus replication |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024535596A true JP2024535596A (ja) | 2024-09-30 |
| JP2024535596A5 JP2024535596A5 (https=) | 2025-10-17 |
| JPWO2023062559A5 JPWO2023062559A5 (https=) | 2025-10-17 |
Family
ID=84044276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522260A Pending JP2024535596A (ja) | 2021-10-13 | 2022-10-12 | ヒト免疫不全ウイルス複製の阻害薬 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240423985A1 (https=) |
| EP (1) | EP4415685A1 (https=) |
| JP (1) | JP2024535596A (https=) |
| KR (1) | KR20240074850A (https=) |
| AU (1) | AU2022362855B2 (https=) |
| CA (1) | CA3234219A1 (https=) |
| CL (1) | CL2024001073A1 (https=) |
| IL (1) | IL311982A (https=) |
| MX (1) | MX2024004551A (https=) |
| WO (1) | WO2023062559A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202128648A (zh) * | 2019-10-04 | 2021-08-01 | 英商Ｖｉｉｖ醫療保健英國(Ｎｏ 5)有限公司 | 人類免疫不全病毒複製之抑制劑 |
| US12594276B2 (en) | 2024-02-05 | 2026-04-07 | Viiv Healthcare Uk (No. 5) Limited | Inhibitors of human immunodeficiency virus replication |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230011471A (ko) * | 2016-08-19 | 2023-01-20 | 길리애드 사이언시즈, 인코포레이티드 | Hiv 바이러스 감염의 예방적 또는 치유적 치료에 유용한 치료 화합물 |
| TWI687415B (zh) * | 2017-08-17 | 2020-03-11 | 美商基利科學股份有限公司 | Hiv蛋白質膜抑制劑之固體形式 |
| CN120053445A (zh) * | 2018-07-16 | 2025-05-30 | 吉利德科学公司 | 用于治疗hiv的衣壳抑制剂 |
| MX2021004593A (es) * | 2018-10-24 | 2021-06-15 | Viiv Healthcare Uk No 5 Ltd | Inhibidores de la replicacion del virus de la inmunodeficiencia humana. |
| LT3986561T (lt) * | 2019-06-19 | 2024-04-25 | VIIV Healthcare UK (No.5) Limited | Pirido[2,3-d]pirimidino dariniai kaip žmogaus imunodeficito viruso replikacijos inhibitoriai |
| CN115397424A (zh) * | 2020-04-15 | 2022-11-25 | Viiv保健英国第五有限公司 | 人类免疫缺陷病毒复制的抑制剂 |
-
2022
- 2022-10-12 US US18/700,402 patent/US20240423985A1/en active Pending
- 2022-10-12 EP EP22797493.8A patent/EP4415685A1/en active Pending
- 2022-10-12 CA CA3234219A patent/CA3234219A1/en active Pending
- 2022-10-12 AU AU2022362855A patent/AU2022362855B2/en active Active
- 2022-10-12 JP JP2024522260A patent/JP2024535596A/ja active Pending
- 2022-10-12 MX MX2024004551A patent/MX2024004551A/es unknown
- 2022-10-12 IL IL311982A patent/IL311982A/en unknown
- 2022-10-12 KR KR1020247014899A patent/KR20240074850A/ko active Pending
- 2022-10-12 WO PCT/IB2022/059780 patent/WO2023062559A1/en not_active Ceased
-
2024
- 2024-04-11 CL CL2024001073A patent/CL2024001073A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4415685A1 (en) | 2024-08-21 |
| IL311982A (en) | 2024-06-01 |
| CL2024001073A1 (es) | 2024-10-04 |
| AU2022362855B2 (en) | 2025-08-14 |
| KR20240074850A (ko) | 2024-05-28 |
| CA3234219A1 (en) | 2023-04-20 |
| AU2022362855A1 (en) | 2024-05-02 |
| MX2024004551A (es) | 2024-06-26 |
| US20240423985A1 (en) | 2024-12-26 |
| WO2023062559A1 (en) | 2023-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI814350B (zh) | 用於治療hiv之蛋白殼抑制劑 | |
| US12497399B2 (en) | Fluorinated integrin antagonists | |
| JP2024535596A (ja) | ヒト免疫不全ウイルス複製の阻害薬 | |
| JP2025509680A (ja) | 治療薬のバイオアベイラビリティを改善した組成物およびその使用 | |
| TW202329976A (zh) | Ｐ１３Ｋ—δ抑制劑之局部調配物 | |
| CN118119376A (zh) | 人类免疫缺陷病毒复制的抑制剂 | |
| TWI922180B (zh) | 用於治療hiv之蛋白殼抑制劑 | |
| HK1248677B (en) | Fluorinated integrin antagonists | |
| TW201717950A (zh) | 用於治療疾病的雜芳基碳化腈 | |
| CN118286216A (zh) | 一种环戊并吡啶衍生物的药物组合物及其制备方法 | |
| HK1217696B (en) | Fluorinated integrin antagonists | |
| HK40040234A (en) | Capsid inhibitors for the treatment of hiv | |
| JP2020515607A (ja) | プロドラッグ組成物 | |
| KR20140102939A (ko) | 포스포다이에스터라제-5 억제제 또는 이의 약학적으로 허용가능한 염을 포함하는 질내 투여용 약학적 조성물 | |
| NZ710447B2 (en) | Fluorinated integrin antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251008 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20251008 |